Found: 12
Select item for more details and to access through your institution.
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 10, p. 18333, doi. 10.3390/ijms151018333
- By:
- Publication type:
- Article
Identification of potential therapeutic targets in prostate cancer through a cross-species approach.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 3, p. 1, doi. 10.15252/emmm.201708274
- By:
- Publication type:
- Article
Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2020, p. 1, doi. 10.1155/2020/2148562
- By:
- Publication type:
- Article
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 349, doi. 10.1186/1471-2407-14-352
- By:
- Publication type:
- Article
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-352
- By:
- Publication type:
- Article
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs).
- Published in:
- BMC Proceedings, 2013, v. 7, n. Suppl 2, p. 1, doi. 10.1186/1753-6561-7-S2-P53
- By:
- Publication type:
- Article
Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2015, v. 19, n. 4, p. 723, doi. 10.1111/jcmm.12481
- By:
- Publication type:
- Article
Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.
- Published in:
- Prostate, 2013, v. 73, n. 7, p. 763, doi. 10.1002/pros.22620
- By:
- Publication type:
- Article
Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.
- Published in:
- EMBO Journal, 2014, v. 33, n. 12, p. 1365, doi. 10.15252/embj.201386874
- By:
- Publication type:
- Article